GALAPAGOS NV

GLPG

Real-time Euronext Amsterdam - 11:35:21 2023-06-08 am EDT
39.56 EUR	-0.13%

Turn to zoom

Prev.	39.56000000
Open	39.65000000
High	40.11000000
Low	39.35000000
Volume	141 733

3d ago	Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase...
3d ago	Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase...
3d ago	Galapagos to Showcase CAR-T Point-Of-Care Manufacturing and Initial Phase...
05/31	JPMorgan Lowers Price Target on Galapagos to $45 From $52, Maintains Neutral...

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bearish
Resistance	41,6	44,0	43,9
Spread/Res.	-4,8%	-10%	-9,8%
Spread/Supp.	5,3%	18%	16%
Support	37,6	33,4	34,1

Sales 2023	533 M 575 M 575 M
Net income 2023	-144 M -155 M -155 M
Net cash 2023	2 075 M 2 236 M 2 236 M
P/E ratio 2023	-15,4x
Yield 2023	-

Capitalization	2 607 M 2 809 M 2 809 M
EV / Sales 2023	1,00x
EV / Sales 2024	1,52x
Nbr of Employees	1 338
Free-Float	73,7%

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. The company is committed to improving patients' lives worldwide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities,...

Sector :

Other Biotechnology & Medical Research

Calendar :

2023-06-09 Presentation

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	HOLD
Number of Analysts	8
Last Close Price	39,56 €
Average target price	40,06 €
Spread / Average Target	1,27%